These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8562586)

  • 21. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use.
    Lanas A; Perez-Aisa MA; Feu F; Ponce J; Saperas E; Santolaria S; Rodrigo L; Balanzo J; Bajador E; Almela P; Navarro JM; Carballo F; Castro M; Quintero E;
    Am J Gastroenterol; 2005 Aug; 100(8):1685-93. PubMed ID: 16086703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
    Lane ME; Kim MJ
    J Pharm Pharmacol; 2006 Oct; 58(10):1295-304. PubMed ID: 17034651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Forty years of ibuprofen use.
    Moore N
    Int J Clin Pract Suppl; 2003 Apr; (135):28-31. PubMed ID: 12723744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.
    Fries JF
    N Engl J Med; 1999 Oct; 341(18):1397-8; author reply 1398-9. PubMed ID: 10577092
    [No Abstract]   [Full Text] [Related]  

  • 25. The management of NSAIDs therapy: how to minimize upper gastrointestinal tract damage.
    Lisotti A; Grenci C; Caponi A; Roda E
    Minerva Gastroenterol Dietol; 2008 Dec; 54(4):323-9. PubMed ID: 19047972
    [No Abstract]   [Full Text] [Related]  

  • 26. Controversies in COX-2 selective inhibition.
    Simon LS; Smolen JS; Abramson SB; Appel G; Bombardier C; Brater DC; Breedveld FC; Brune K; Burmester GR; Crofford LJ; Dougados M; DuBois RN; Fitzgerald GA; Frishman W; García Rodríguez LA; Hochberg MC; Kalden JR; Laine L; Langman MJ; Prescott SM; van de Putte LB; Whelton A; White WB; Willaims GH
    J Rheumatol; 2002 Jul; 29(7):1501-10. PubMed ID: 12136912
    [No Abstract]   [Full Text] [Related]  

  • 27. Epidemiology of NSAID induced gastrointestinal complications.
    Singh G; Triadafilopoulos G
    J Rheumatol Suppl; 1999 Apr; 56():18-24. PubMed ID: 10225536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gastropathy by NSAID].
    Pérez Manauta J
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():24-5. PubMed ID: 17471850
    [No Abstract]   [Full Text] [Related]  

  • 29. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs.
    van der Linden MW; van der Bij S; Welsing P; Kuipers EJ; Herings RM
    Ann Rheum Dis; 2009 May; 68(5):668-73. PubMed ID: 18495734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada.
    Rahme E; Barkun A; Nedjar H; Gaugris S; Watson D
    Am J Gastroenterol; 2008 Apr; 103(4):872-82. PubMed ID: 18371130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk and prevention of gastrointestinal complications due to low-dose aspirin and other antiplatelet agents].
    Bretagne JF
    Rev Prat; 2008 Sep; 58(13):1434-6, 1439-40. PubMed ID: 18924327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin.
    ; Wilcox CM; Allison J; Benzuly K; Borum M; Cryer B; Grosser T; Hunt R; Ladabaum U; Lanas A; Paulus H; Regueiro C; Sandler RS; Simon L
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1082-9. PubMed ID: 16877048
    [No Abstract]   [Full Text] [Related]  

  • 33. [When and why should we eradicate the Helicobacter pylori?].
    Perez Perez GI
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():26-7. PubMed ID: 17471851
    [No Abstract]   [Full Text] [Related]  

  • 34. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
    Russell RI
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
    Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN
    Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gastrointestinal side effects of non-steroidal anti-inflammatory agents and costs in the National Health System].
    Lanas A
    An Med Interna; 2001 Nov; 18(11):561-3. PubMed ID: 11862764
    [No Abstract]   [Full Text] [Related]  

  • 37. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
    Biskupiak JE; Brixner DI; Howard K; Oderda GM
    J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of low-dose aspirin: emphasis on outliers undermines the credibility of the conclusions.
    Graham DY
    Aliment Pharmacol Ther; 2007 Feb; 25(3):345-6; author reply 346-7. PubMed ID: 17217449
    [No Abstract]   [Full Text] [Related]  

  • 39. Gastrointestinal safety of low-dose aspirin.
    Cryer B
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S701-8. PubMed ID: 12512737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoporosis therapies for rheumatoid arthritis patients: minimizing gastrointestinal side effects.
    Sewell K; Schein JR
    Semin Arthritis Rheum; 2001 Feb; 30(4):288-97. PubMed ID: 11182029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.